Viatris Inc
Change company Symbol lookup
Select an option...
VTRS Viatris Inc
CHMR Chimera Energy Corp
QTRX Quanterix Corp
MSEX Middlesex Water Co
EQIX Equinix Inc
PEAK Healthpeak Properties Inc
TAL TAL Education Group
CPLP Capital Product Partners LP
ONFO Onfolio Holdings Inc
CALB California BanCorp
Go

Health Care : Pharmaceuticals | Mid Cap Value
Company profile

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Closing Price
$9.21
Day's Change
0.49 (5.62%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.21
Day's Low
8.79
Volume
(Below Average)
Volume:
8,796,084

10-day average volume:
10,546,291
8,796,084

Display:

Providers:

UpdateCancel
6 providers
September 28, 2022
Thinking about buying stock in Cisco Systems, Viatris, American Virtual Cloud Technologies, Yamana Gold, or Top Ships?

InvestorsObserver issues critical PriceWatch Alerts for CSCO, VTRS, AVCT, AUY, and TOPS. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

September 21, 2022
Mapi Pharma Announces Positive Top-Line Results from GA Depot Phase III Trial for Relapsing forms of Multiple Sclerosis (RMS)

EQNX::TICKER_START (NASDAQ:VTRS), EQNX::TICKER_END Mapi Pharma Ltd., a fully integrated, late-stage clinical development pharmaceutical company focused on introducing innovative long-acting depot injectable products, announced today positive...(Globe Newswire)

September 06, 2022
Viatris Inc. to Participate in BofA Global Research Global Healthcare Conference

Viatris Inc. (NASDAQ: VTRS), a global pharmaceutical company, today announced the company will participate in the BofA Global Research Global Healthcare Conference in London on Thursday, September 15, 2022. Chief Executive Officer Michael Goettler...(PR Newswire)

August 08, 2022
Viatris Reports Strong Second Quarter 2022 Results

-- Reports Total Revenues of $4.12 Billion; U.S. GAAP Net Earnings of $314 Million; Adjusted EBITDA of $1.48 Billion; U.S. GAAP Net Cash Provided by Operating Activities of $803 Million; and Free Cash Flow of $719 Million (PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.